Sleep disturbances among HIV-positive adultsThe role of pain, stress, and social support

Vosvick, Mark A.; Gore‐Felton, Cheryl; Ashton, E. H.; Koopman, Cheryl; Fluery, Theresa; Israelski, Dennis; Spiegel, Davis

doi:10.1016/s0022-3999(04)00445-3

Cited by 33 publications

(42 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Approximately one third of the general population reports occasional sleep problems, and about 10% have chronic insomnia (Roth, 2005;Fullerton, 2006). Sleep difficulty is associated with high rates of physical illness, psychiatric disorders, accidents, health care service utilization, social network problems, and employment-related difficulties (Roth et al, 2006;Sateia & Pigeon, 2004;Ohayona & Roth, 2003;Tjepkema, 2005;Vosvick et al, 2004). Many people with sleep problems have a greater tendency to use both licit and illicit substances to attempt to improve sleep functioning (e.g., Crum, Ford, Storr & Chan, 2004;Johnson, Roehrs, Roth & Breslau, 1998).…”

Section: Introductionmentioning

confidence: 99%

Sleep problems reported by patients entering opioid agonist treatment

Burke

Peirce

Kidorf

et al. 2008

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Treatment-seeking opioid dependent individuals frequently report sleep-related problems (Dyer & White, 1997;Puigdollers et al., 2004). The present study provides a detailed assessment of sleep duration and quality in this population, including their effect on daily functioning and relationship to psychiatric severity and drug use. New admissions to opioid-agonist maintenance treatment (n = 113) completed a series of questionnaires to assess sleep functioning, psychiatric severity, and drug use due to sleep problems over the past 30-days. The results showed that study participants reported considerable sleep-related difficulties that had little effect on their appraisals of daily functioning. Nevertheless, sleep problems were associated with psychiatric distress, and those reporting substance use specifically to increase or decrease sleepiness endorsed more sleep problems and lower levels of daily functioning. Overall, these results replicate and extend previous work showing poor sleep functioning in this population, and show that sleep problems are associated with variables that often have an adverse impact on substance abuse treatment outcome.

show abstract

Section: Introductionmentioning

confidence: 99%

Sleep problems reported by patients entering opioid agonist treatment

Burke

Peirce

Kidorf

et al. 2008

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

show abstract

“…The characterization of the 33 articles showed that the year of publication ranged 1994-2013, being published in 15 European countries, [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] in the United States, 1,24-37 two in Brazil [38][39] and one in Argentina. 40 As the evidence levels, 8 there was the following distribution: an article level II, 31 an article level IV 11 articles level VI.…”

Section: Resultsmentioning

confidence: 99%

“…40 As the evidence levels, 8 there was the following distribution: an article level II, 31 an article level IV 11 articles level VI. 1,[9][10][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][32][33][34][35][36][37][38][39][40] It was found that most of the findings were derived from cross-sectional and descriptive studies, occurring direct observation of a planned number of people with HIV/ AIDS in a lifetime opportunity, which prevents comparisons of long-term sample characteristics.…”

Section: Resultsmentioning

confidence: 99%

“…According to the studies analyzed, most people satisfied with social support they receive, have fewer symptoms of HIV infection, which can be reflected by an increase in lymphocyte count CD4 +, 9,11 with the viral load reduction, 13 increased selfefficacy in conducting the treatment 20 and the reduction of sleep-related problems. 12 These findings may be related to treatment adherence.…”

Section: Discussionmentioning

confidence: 98%

“…13 In PLHIV, social support deficit is associated with sleep problems. 12 Satisfactory social support relates to increased selfefficacy, to high levels of education and income, in addition to increased CD4 + T lymphocytes count in PLHIV. 20 Social support was also associated with improvements in quality of life PLHIV, which can increase the survival of these individuals.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Efeito do suporte social na vida de adultos com HIV/AIDS Effect of social support in the lives of adults with HIV/AIDS

Galvão

2016

R. pesq. cuid. fundam. online

View full text Add to dashboard Cite

Objetivo: Analisar o efeito do suporte social na vida de pacientes adultos com Vírus da Imunodeficiência Humana (HIV)/Síndrome da Imunodeficiência Adquirida (aids). Método: A revisão integrativa da literatura foi realizada em seis bases de dados, entre os meses de agosto a outubro de 2014. Utilizaram-se os descritores aids e suporte social, nos idiomas português, inglês ou espanhol e o operador booleano and. Foram encontrados 1.561 artigos e selecionados 33. Resultados: Identificou-se que o suporte social tem efeito positivo sobre a saúde mental, aderência à terapia antirretroviral, estado de saúde, qualidade de vida e manutenção do sexo seguro. Conclusão: Considera-se que o estabelecimento de relações mais profundas entre o suporte social e outros aspectos da vida das pessoas com HIV/aids, possam ser utilizados para a promoção da saúde desses indivíduos, com o intuito de diminuir a morbidade e aumentar a sobrevida desses pacientes. Descritores: HIV, Síndrome de Imunodeficiência Adquirida, Apoio Social.

show abstract

Psychological Co-morbidities of Physical Illness

Pagoto¹

2011

View full text Add to dashboard Cite

except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) v Individuals with psychological disorders are disproportionately affected by chronic disease, which presents a significant health disparity that is underrecognized and underaddressed. Physical and psychological illnesses co-occur more often than not in clinical populations, and this co-occurrence is associated with greater impairment, lower adherence, poor treatment response, lower quality of life, increased healthcare costs, and higher mortality rates. This book is the first comprehensive resource regarding psychological co-morbidities of physical illness. It serves as both a handbook for clinicians who care for patients with co-morbidities as well as a call for research that increases our understanding of the connection between physical and psychological illness, with the ultimate goal of improving the health of people with psychological disorders.A constellation of behavioral, pharmacological, and physiological factors play a role in the increased risk for disease among individuals with psychological disorders. Behavioral factors include higher rates of smoking, obesity, and unhealthy behaviors. Psychopharmacology has also been implicated given that many drugs promote weight gain and metabolic syndrome. Physiological processes of psychological distress, including hypothalamic-pituitary-adrenal axis dysfunction, inflammation, and autonomic dysfunction, can also manifest in the development of chronic disease. In addition to identifying the most prevalent psychological co-morbidities of physical illness, this book explores how behavioral, pharmacological, and physiological factors converge to put individuals with psychological disorders at greater risk for disease.This book is firmly rooted in the philosophy of evidence-based practice and was designed to help narrow the existing research to practice gap. One of the most commonly cited reasons by clinicians for not using evidence-based treatments is that randomized clinical trials do not reflect their consumers who have multiple co-morbidities. Traditionally, randomized clinical trials, by having a disease-specific focus...

show abstract

Sleep disturbances among HIV-positive adultsThe role of pain, stress, and social support

Cited by 33 publications

References 0 publications

Sleep problems reported by patients entering opioid agonist treatment

Sleep problems reported by patients entering opioid agonist treatment

Efeito do suporte social na vida de adultos com HIV/AIDS Effect of social support in the lives of adults with HIV/AIDS

Psychological Co-morbidities of Physical Illness

Contact Info

Product

Resources

About